Clinical Trials Logo

Burns clinical trials

View clinical trials related to Burns.

Filter by:

NCT ID: NCT02673229 Recruiting - Clinical trials for Burn, Partial Thickness

Comparison of Collagenase Santyl Ointment With Antibiotic Ointment in the Outpatient Care of Minor Partial Thickness Burns

Start date: January 2014
Phase: Phase 4
Study type: Interventional

By doing this study, researchers hope to learn if applying Santyl to the burn during the healing process affects the appearance of the resulting scar.

NCT ID: NCT02672280 Not yet recruiting - Burns Clinical Trials

Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects

SEESCMMSCTSD
Start date: May 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the present study is to evaluate the safety and exploratory efficacy of the medical collagen membrane with umbilical cord derived mesenchymal stem cells in the treatment of patients with skin defects.

NCT ID: NCT02661724 Completed - Burn Related Pain Clinical Trials

Take Charge of Burn Pain

Start date: April 2015
Phase: N/A
Study type: Interventional

Persons with burn-related pain remain under treated and do not have access to comprehensive burn pain management. We seek to extend evidence-based cognitive behavioral pain management strategies to a group of burn survivors that are currently under treated for for burn pain with a specific goal of reducing pain related interference in life activities. Investigators will conduct a randomized controlled trial to test the central hypothesis that a computer-based cognitive-behavioral program (Take Charge of Burn Pain) will improve pain management, psychological health, and improve participation in burn survivors. Specific aims include: 1) to determine the efficacy of a web-based self-management intervention in reducing pain and pain-related interference and increasing pain management self-efficacy; and 2) to determine whether Take Charge of Burn Pain improves psychological health and participation in life activities in persons with burn injury pain. Emerging research suggests that web-based pain management interventions may be a feasible and effective alternative to clinic-based interventions for patients with mobility and geographic restrictions, such as those treated at tertiary burn centers.

NCT ID: NCT02660541 Completed - Acute Burn Clinical Trials

Burn Wound Management of Betafoam® and Allevyn® Ag

Start date: June 21, 2016
Phase: N/A
Study type: Interventional

This is a randomized, controlled, multi-centre, open-label study. A total of 40 patients will be enrolled in this study. Patients will be randomly assigned to Betafoam® or Allevyn® Silver dressing for burn wounds after acute burn injury.

NCT ID: NCT02619851 Completed - Burn Injury Clinical Trials

A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects

Start date: December 23, 2015
Phase: Phase 2
Study type: Interventional

This clinical trial is a Phase II controlled, parallel, open-label trial, designed to test the efficacy and safety of ALLO-ASC-DFU and conventional therapy in Deep Second-degree burn wound subjects.

NCT ID: NCT02607852 Active, not recruiting - Burns Clinical Trials

Feedback System of PROMS in Children With Burns

Start date: April 8, 2015
Phase: N/A
Study type: Interventional

The primary objective of the overall study is to determine the feasibility and usefulness of a feedback system that delivers BOQ results to physicians in "real time" during outpatient encounters using iPads.

NCT ID: NCT02580734 Completed - Clinical trials for Burning Mouth Syndrome

Efficacy of Melatonin in Burning Mouth Syndrome (BMS)

BMS2013
Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether melatonin is effective in the treatment of burning mouth syndrome (BMS).

NCT ID: NCT02537821 Recruiting - Clinical trials for Severely Burned Patients

HLA Sensitization in Severely Burned Patients

Start date: June 2015
Phase: N/A
Study type: Observational

Primary goal of this study is the analysis of HLA (Human leucocyte antigen) formation in severly burned patients. Potential HLA triggers in the treatment of severely burned patients are blood products, assist devices or temporary allogeneic skin. Besides that, inflammatory markers, such as WBC (white blood cell count), CRP (C-reactive protein), PCT (Procalcitonin) and two novel biomarkers (PSP (pancreatic stone protein), ST2) are to be investigated in severely burned patients.

NCT ID: NCT02501720 Not yet recruiting - Flexion Contracture Clinical Trials

Comparison of Outcome of Post Burn Flexion Contracture Release Under Tourniquet Verses Tumescent Technique in Children

Start date: September 2015
Phase: N/A
Study type: Interventional

Post burn flexion contractures are common in pediatric age group. Release of contracture and coverage with full thickness skin graft (FTSG) is a widely used procedure for this problem. This procedure is routinely done under tourniquet control because bloodless operative field is essential to visualize important neurovascular structures in hand. Use of tumescent technique without a tourniquet is gaining acceptance because it avoids complications associated with tourniquet use, maintains a blood less surgical field and decreases operative time. Furthermore use of tumescent anesthesia often results in better surgical outcomes. Although the benefits of tumescent technique used in wide awake hand surgery are well documented, epinephrine at a concentration of 1:1 000,00 has also been used as a replacement for pneumatic tourniquet for release of hand contracture in infants and adults under general anesthesia. Thus epinephrine 1:1,000,00 in saline solution can be a potential replacement for a tourniquet in hand surgeries done under general anesthesia.

NCT ID: NCT02497326 Recruiting - Second Degree Burns Clinical Trials

Heparin for the Treatment of Burn Wound Pain

Start date: April 2015
Phase: N/A
Study type: Interventional

Pain Associated with partial thickness burns (PTB) is very severe and distressing for the patients.Topical conventional treatment of superficial PTB wounds includes application of polyfax skin ointment plus lignocain gel twice a day after wound wash while deep PTB are treated with silvazine cream twice a day and prepared for grafting if not healed within 3 weeks. Existing conventional therapy is un-comfortable and expensive for the patients. Search continues for a reliable, safe, cheap and effective treatment of burn.Topical use of heparin has been found effective in reducing pain associated with burn wounds. More over use of heparin topically in burn patients is easy to perform and cheap but at the moment, evidence of its effectiveness is weak. Current study is being conducted to verify clinical effectiveness of use of heparin in 2nd degree burns by comparing it with topical conventional treatment.